Nor-MDP, Saponin, Corynebacteria, and Pertussis Organisms As Immunological Adjuvants in Experimental Malaria Vaccination of Macaques
Overview
Affiliations
Vaccination of primates against malaria using antigen derived from erythrocytic parasite stages has been most successful where Freund's complete adjuvant has been employed. Since this adjuvant is clinically unacceptable its replacement is a matter of urgency.In the present work a muramyldipeptide derivative (nor-MDP) given in mineral oil has proved to be partially effective as an adjuvant for merozoite vaccination of Macaca mulatta against Plasmodium knowlesi, and saponin has proved to be effective in similar vaccination of M. fascicularis.
Burns Jr J, Dunn P, Russo D Infect Immun. 1997; 65(8):3138-45.
PMID: 9234766 PMC: 175443. DOI: 10.1128/iai.65.8.3138-3145.1997.
Malaria: immunity and prospects for vaccination.
Hommel M West J Med. 1981; 135(4):285-99.
PMID: 7043898 PMC: 1273171.
Muramyl peptides. Chemical structure, biological activity and mechanism of action.
Adam A, PETIT J, Lefrancier P, Lederer E Mol Cell Biochem. 1981; 41:27-47.
PMID: 7035868 DOI: 10.1007/BF00225295.
A perspective on malaria vaccines.
Desowitz R, MILLER L Bull World Health Organ. 1980; 58(6):897-908.
PMID: 6783333 PMC: 2396002.
Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.
Champsi J, McMahon-Pratt D Infect Immun. 1988; 56(12):3272-9.
PMID: 3182080 PMC: 259734. DOI: 10.1128/iai.56.12.3272-3279.1988.